Soleno Therapeutics (SLNO) Prepaid Assets (2013 - 2026)

Soleno Therapeutics' (SLNO) quarterly Prepaid Assets came in at $6.3 million in Q1 2026, down 66.62% year-on-year from $19.0 million in Q1 2025, and down 10.97% on a QoQ basis from $7.1 million in Q4 2025.

Soleno Therapeutics (SLNO) Prepaid Assets (2013 - 2026) Analysis & Trends

Soleno Therapeutics (SLNO) has 14 years of Prepaid Assets data on file, last reported at $6.3 million in Q1 2026.

  • On a quarterly basis, Prepaid Assets fell 66.62% year-over-year to $6.3 million in Q1 2026; TTM through Mar 2026 was $6.3 million, a 66.62% decrease from a year earlier, with the FY2025 full-year figure at $7.1 million, up 189.97% from the prior year.
  • Prepaid Assets for Q1 2026 stood at $6.3 million, down from $7.1 million in the prior quarter.
  • Over the last five years, Prepaid Assets for SLNO reached as high as $19.0 million in Q1 2025 and fell as low as $821000.0 in Q3 2022.
  • Historically, Prepaid Assets has averaged $3.2 million across 5 years, with a median of $1.4 million in 2024.
  • Across the five-year window, Prepaid Assets soared 1088.28% in 2025 and tumbled 66.62% in 2026, its largest moves.
  • Year by year, Prepaid Assets stood at $1.0 million in 2022, then jumped by 60.48% to $1.7 million in 2023, then soared by 46.21% to $2.5 million in 2024, then soared by 189.97% to $7.1 million in 2025, then retreated by 10.97% to $6.3 million in 2026.
  • Per Business Quant data, the three most recent Prepaid Assets figures were $6.3 million in Q1 2026, $7.1 million in Q4 2025, and $3.7 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Soleno Therapeutics 874.25 Mn 618.67 Mn 93.41 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 6.33 Mn
Dec 31, 2025 7.11 Mn
Sep 30, 2025 3.74 Mn
Jun 30, 2025 2.97 Mn
Mar 31, 2025 18.97 Mn
Dec 31, 2024 2.45 Mn
Sep 30, 2024 1.42 Mn
Jun 30, 2024 1.38 Mn
Mar 31, 2024 1.60 Mn
Dec 31, 2023 1.68 Mn
Sep 30, 2023 1.22 Mn
Jun 30, 2023 1.13 Mn
Mar 31, 2023 1.25 Mn
Dec 31, 2022 1.05 Mn
Sep 30, 2022 821,000.00
Jun 30, 2022 824,000.00
Mar 31, 2022 1.00 Mn
Dec 31, 2021 1.12 Mn
Sep 30, 2021 702,000.00
Jun 30, 2021 948,000.00